Transaction in Own Shares

Fidelity Emerging Markets Limited repurchased and cancelled 132,289 shares on 21 January 2026 at an average price of 1,150.51 GBp (low 1,144.00 GBp; high 1,154.00 GBp). Post-transaction issued share capital stands at 52,509,697 shares, with 9,025,940 held in treasury and total voting rights of 43,483,758; the buyback is a small (~0.25% of issued capital) capital return that marginally concentrates equity and signals modest shareholder-return activity by the board.

Analysis

Market structure: The repurchase (132,289 shares at an average 1,150.51 GBp = ca. £1.52m) is small — ~0.25% of issued share capital — but meaningful for a closed‑end vehicle: it reduces free float and increases NAV per share by roughly £1.52m / 43.48m voting rights ≈ £0.035 (~3.5 GBp), or ~0.3% of the current price. Immediate beneficiaries are remaining shareholders (modest EPS/NAV accretion) and yield/discount‑seeking investors; liquidity providers may see slightly wider spreads. Passive EM ETFs/ETFs replicating index exposure are neutral-to-loser since closed‑end funds can now more actively manage discounts via buybacks.

Risk assessment: Tail risks include an EM asset price shock after buybacks (management buys high, NAV falls) and regulatory limits on buybacks; operational risk is negligible. Time horizons: days — potential small price pop (≤1–2%); weeks/months — discount-to-NAV may compress by 50–150bp if buybacks persist; quarters — impact depends on program scale (if monthly repurchases accelerate, effect compounds). Hidden dependency: funding source — using cash reduces liquidity cushions; using leverage increases downside risk.

Trade implications: Direct: asymmetric long in Fidelity Emerging Markets Limited (London‑quoted closed‑end EM fund) sized 1–3% portfolio if discount >3% and hold 3–6 months; target exit when discount narrows 100–150bp or price returns ≥4–6%. Pair: go long Fidelity EM fund vs short iShares MSCI Emerging Markets ETF (EEM) or VWO (weight 0.5–1% net market‑neutral) to isolate discount compression. Options: consider selling 3‑month cash‑secured puts 5% OTM (max allocation 1–2%) to collect premium and set acquisition price.

Contrarian angles: The market may overrate the signal — this buyback yields only ~0.3% NAV uplift, so any >1% price jump is likely overdone unless management commits to a sustained program. Conversely, if management continues repurchases at this cadence monthly, cumulative uplift becomes non‑trivial; monitor buyback cadence and net cash/debt for 30–90 days. Historical parallels: small tactical buybacks in UK closed‑end funds often precede 3–6 month discount compression, but can reverse quickly in EM selloffs. Unintended consequence: reducing float may deter institutional buyers and increase volatility; size positions accordingly.

Key Decisions for Investors

• Establish a 1–3% long position in Fidelity Emerging Markets Limited (London‑quoted closed‑end EM fund) within 5 trading days if current discount-to-NAV exceeds 3%; hold 3–6 months and take profits when discount narrows by 100–150bp or share price rises 4–6%.
• Initiate a market‑neutral pair trade: long Fidelity Emerging Markets Limited (0.5–1% portfolio) and short iShares MSCI Emerging Markets ETF (EEM) or Vanguard FTSE Emerging Markets (VWO) equal notional to isolate discount compression; reassess after 60–90 days or after two further monthly repurchases.
• Sell 3‑month cash‑secured puts 5% OTM on Fidelity Emerging Markets Limited (max 1–2% portfolio risk) to collect premium and set an effective buy price ~5% below today; close if implied vol increases >50% or if NAV falls >5% in 14 days.
• Reduce passive EM ETF exposure by 1–2% in favor of active/closed‑end EM funds with demonstrated buyback programs if overall EM risk budget is constrained; reallocate only after verifying buyback funding source (cash vs. debt) within 30 days.